David R Epstein Rubius Therapeutics, Inc. (RUBY) insider trading activity

RUBY Quotes by TradingView

David R Epstein is Director of Rubius Therapeutics, Inc.. Currently has a direct ownership of 4.72 Million shares of RUBY, which is worth approximately $0. The most recent transaction as insider was on Apr 21, 2022, when has been sold 30,000 shares (Common Stock) at a price of $1.44 per share, resulting in proceeds of $43,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.72M
0% 3M change
0% 12M change
Total Value Held $0

David R Epstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 21 2022
BUY
Open market or private purchase
$43,200 $1.44 p/Share
30,000 Added 0.63%
4,720,012 Common Stock
Feb 11 2021
SELL
Open market or private sale
$398,691 $14.93 p/Share
26,704 Reduced 0.57%
4,690,012 Common Stock
Feb 10 2021
SELL
Open market or private sale
$109,505 $14.79 p/Share
7,404 Reduced 0.16%
4,716,716 Common Stock
Feb 09 2021
SELL
Open market or private sale
$31,143 $14.83 p/Share
2,100 Reduced 0.04%
4,724,120 Common Stock
Feb 08 2021
SELL
Open market or private sale
$1,327,787 $14.88 p/Share
89,233 Reduced 1.85%
4,726,220 Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
CEO
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials
Director
EVLO
Evelo Biosciences, Inc. Healthcare
Director
AXLA
Axcella Health Inc. Healthcare
Director
SNTI
Senti Biosciences, Inc. Healthcare
Director
TEM
Tempus AI, Inc.
DRE

David R Epstein

Director
South San Francisco, CA

Track Institutional and Insider Activities on RUBY

Follow Rubius Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RUBY shares.

Notify only if

Insider Trading

Get notified when an Rubius Therapeutics, Inc. insider buys or sells RUBY shares.

Notify only if

News

Receive news related to Rubius Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RUBY